4.8 Article

dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway

Journal

SCIENCE
Volume 337, Issue 6093, Pages 481-484

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1223899

Keywords

-

Funding

  1. U.S. Department of Defense [BC093796]
  2. National Institute for Neurological Diseases and Stroke (NINDS) [R01NS072248, U54NS065712, R01NS059991]
  3. Alzheimer's Research UK [ART/PG2009/2]
  4. Biotechnology and Biological Sciences Research Council Institute
  5. NIH [AI030165]
  6. Rockefeller University
  7. ALS Therapy Alliance
  8. NINDS ARRA [RC2-NS070-342]
  9. Angel Fund
  10. ALS Association
  11. P2ALS
  12. ALS
  13. Pierre L. de Bourgknecht ALS Research Foundation
  14. [NINDS5RO1-NS050557-05]
  15. Alzheimers Research UK [ART-PG2009-2] Funding Source: researchfish
  16. Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C200, BBS/E/B/000C0417] Funding Source: researchfish
  17. BBSRC [BBS/E/B/000C0417] Funding Source: UKRI

Ask authors/readers for more resources

Axonal and synaptic degeneration is a hallmark of peripheral neuropathy, brain injury, and neurodegenerative disease. Axonal degeneration has been proposed to be mediated by an active autodestruction program, akin to apoptotic cell death; however, loss-of-function mutations capable of potently blocking axon self-destruction have not been described. Here, we show that loss of the Drosophila Toll receptor adaptor dSarm (sterile alpha/Armadillo/Toll-Interleukin receptor homology domain protein) cell-autonomously suppresses Wallerian degeneration for weeks after axotomy. Severed mouse Sarm1 null axons exhibit remarkable long-term survival both in vivo and in vitro, indicating that Sarm1 prodegenerative signaling is conserved in mammals. Our results provide direct evidence that axons actively promote their own destruction after injury and identify dSarm/Sarm1 as a member of an ancient axon death signaling pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available